Effect of gender on treatment, resource utilization, and outcomes in congestive heart failure in Quebec, Canada

Richard Sheppard1, Hassan Behlouli, Hugues Richard

  • 1Sir Mortimer B. Davis/Jewish General Hospital, Montreal, Quebec, Canada.

Insights

Despite receiving less cardiac care, women with congestive heart failure (CHF) experienced similar health outcomes to men. This study found no significant gender gap in mortality for CHF patients.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Congestive heart failure (CHF) affects millions globally, with potential disparities in care based on gender.
  • Understanding gender-based differences in treatment and outcomes is crucial for equitable healthcare delivery.

Purpose of the Study:

  • To investigate potential gender disparities in the utilization of therapies and procedures for patients newly diagnosed with congestive heart failure (CHF).
  • To compare clinical outcomes between men and women diagnosed with CHF at a population level.

Main Methods:

  • A cohort of 16,017 men and 16,622 women diagnosed with CHF between 1998 and 2002 was identified using linked Quebec healthcare databases.
  • Data included demographics, comorbidities, healthcare utilization (cardiologist visits, hospital stay), procedures (left ventricular function assessment, cardiac catheterization, revascularization), medication use (ACE inhibitors, beta-blockers), and mortality.
  • Statistical analyses were performed to compare characteristics, treatment patterns, and outcomes between genders, adjusting for relevant factors.

Main Results:

  • Women with CHF were older and had higher rates of hypertension and hyperlipidemia but lower rates of myocardial infarction compared to men.
  • Women were less likely to see a cardiologist, undergo diagnostic cardiac catheterization or revascularization, and were prescribed ACE inhibitors less frequently.
  • Despite these differences in care, women and men had similar rates of CHF rehospitalization and emergency room visits, with a minimally higher adjusted risk of death in men.

Conclusions:

  • This population-level study indicates that women with newly diagnosed congestive heart failure receive less aggressive cardiac care, including fewer procedures and less frequent specialist consultations.
  • However, clinical outcomes, including mortality and rehospitalization rates, were similar between men and women with CHF.
  • Further research is warranted to explore the reasons for these observed treatment patterns and to ensure optimal, equitable care for all CHF patients.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...